Stem Cell Manufacturing Market to Grow with a CAGR of 12.64% through 2030F
Increase in the number of cell therapy production
facilities and rising number of clinical trials are expected to drive the
Global Stem Cell Manufacturing Market growth in the forecast period,
2026-2030.
According to TechSci Research report, “Stem Cell
Manufacturing Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2030”, the Global Stem Cell Manufacturing
Market stood at USD 11.25 billion in 2024 and is anticipated to grow with a
CAGR of 12.64% through 2030. The growing development of precision medicine,
increase in the number of cell therapy production facilities and rising number
of clinical trials are expected to be major driving factors of the market.
Recent advances in stem cells therapeutics and tissue engineering hold the
potential to draw attention for treatment of several diseases. The increasing
demand for stem cells banking and rise in research activities pertaining to
stem cells production, storage, and characterization are also expected to fuel
the revenue growth for the market. Technological improvements in the parent and
ancillary market for stem cells usage are some of the other factors that
reinforce the expected growth in demand for stem cells over the forecast
period. Regenerative medicine based on cellular therapies may be a
treatment option for patients, resulting in a reduction in mortality and
infection rates. Companies and research institutes are collaborating to develop
novel treatment options for the disease.
Growing demand for regenerative medicines is expected to fuel market growth. Regenerative medicines have extensive applications in the treatment of various diseases including neurology, oncology, hepatology, diabetes, injuries, hematology, and orthopedics. In addition, growing geriatric population and increasing demand for regenerative medicines for early detection and prevention of diseases are some of the factors contributing to market growth. Regenerative medicines help in restoring normal functioning of cells. Rapid advancements in this field is anticipated to provide effective therapies for chronic conditions.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "Global Stem Cell Manufacturing Market”
The Global Stem Cell Manufacturing Market is segmented into
Product, Application, End User, and company.
Based on End User, the Pharmaceutical and Biotechnology
Companies segment has emerged as the predominant market leader, the segment
will continue to grow at a significant rate during the forecast period. Some of
the factors that can be attributed to the segment's share are rising prevalence
of chronic disease, increase in clinical trials, upsurge in strategic
activities along with improvements in healthcare services.
Based on region, the Asia-Pacific region is the
fastest-growing segment in the global stem cell manufacturing market due to a
combination of factors that create a conducive environment for growth. Key
among these is strong government support through funding, favorable
regulations, and national health initiatives promoting regenerative medicine
and biotechnology. Countries like Japan, South Korea, China, and India are
making significant investments in stem cell research and infrastructure, with
Japan leading in iPSC technology and fast-track regulatory pathways. The region
also benefits from a large and aging population, driving demand for advanced
treatments for chronic and degenerative diseases. The availability of
skilled labor, lower manufacturing costs, and growing collaborations between
academic institutions and biotech companies have made Asia-Pacific an
attractive destination for stem cell manufacturing. Local companies are
increasingly engaging in clinical trials and commercialization of stem cell therapies,
further accelerating growth. The rising medical tourism, particularly in
countries like India and Thailand, enhances access to these therapies.
Altogether, these factors position Asia-Pacific as a dynamic and rapidly
advancing hub in the global stem cell manufacturing landscape.
Major companies operating in Global Stem Cell
Manufacturing Market are:
· Thermo
Fisher Scientific.
· Merck
KGaA.
· AbbVie
Inc.
· ANTEROGEN.CO.
LTD.
· Astellas
Pharma Inc.
· Bristol-Myers
Squibb Company.
· FUJIFILM
Cellular Dynamics Inc.
· RHEACELL
GmbH And Co. KG.
· Takeda
Pharmaceutical Company Limited.
· Teva
Pharmaceutical Industries Ltd.
Download Free Sample Report
Customers can also request 10% free customization on this
report.
“Significant R&D spending is a key driver of growth in
the stem cell manufacturing market. Rising demand for effective therapies to
reduce disease burden further fuels this expansion. The growing recognition of
precision medicine is also boosting market momentum, as scientists develop new
procurement methods for personalized treatments. Key industry players are
leveraging partnerships, mergers, acquisitions, and geographic expansion to
strengthen their positions. Government funding aimed at accelerating stem cell
research adds further momentum to market growth. These combined factors,
including innovation, strategic collaborations, and supportive policies, are
shaping a robust and rapidly expanding stem cell manufacturing landscape” said
Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Stem Cell Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Product (Consumables, Instruments, Stem Cell Lines), By Application (Research Applications, Clinical Application, Cell and Tissue Banking Applications), By End User (Pharmaceutical and Biotechnology Companies, Academic Institutes, Research Laboratories and Contract Research Organizations, Hospitals and Surgical Centers, Cell and Tissue banks, Others), By Region &Competition 2020-2030F”, has evaluated
the future growth potential of Global Stem Cell Manufacturing Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Stem Cell Manufacturing Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com